摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

氯代石蜡 | 90952-64-0

中文名称
氯代石蜡
中文别名
6-氯-N-乙基-N'-丙基-1,3,5-三嗪-2,4-二胺
英文名称
atrazine
英文别名
6-chloro-N-ethyl-N'-propyl-[1,3,5]triazine-2,4-diamine;2-chloro-4-ethylamino-6-(n-propylamino)-[1,3,5]triazine;2-Aethylamino-4-chlor-6-propylamino-s-triazin;2-Chlor-4-aethylamino-6-propylamino-s-triazin;Atrazin;6-chloro-N-ethyl-N'-propyl-1,3,5-triazine-2,4-diamine;6-chloro-4-N-ethyl-2-N-propyl-1,3,5-triazine-2,4-diamine
氯代石蜡化学式
CAS
90952-64-0
化学式
C8H14ClN5
mdl
MFCD00466645
分子量
215.686
InChiKey
MKPLRLYVGXPSQU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    200-202 °C
  • 沸点:
    376.0±25.0 °C(Predicted)
  • 密度:
    1.272±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    62.7
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 危险等级:
    IRRITANT

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    氯代石蜡盐酸N,N-二异丙基乙胺 作用下, 以 乙醇 为溶剂, 反应 16.0h, 生成 N-(4-ethylamino-6-(n-propylamino)-[1,3,5]triazin-2-yl)-N,O-dimethyl-hydroxylamine hydrochloride
    参考文献:
    名称:
    [EN] NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
    [FR] NOUVEAUX COMPOSÉS COMME STIMULANTS RESPIRATOIRES POUR LE TRAITEMENT DE TROUBLES OU DE MALADIES DE CONTRÔLE DE LA RESPIRATION
    摘要:
    本发明涵盖了用于治疗患有呼吸控制疾病或紊乱的受试者的组合物。本发明还包括一种治疗患有呼吸系统疾病或紊乱的受试者的方法,包括向受试者施用本发明的药物配方的治疗有效量。本发明还包括一种预防或稳定患有呼吸节律不稳定的受试者的方法,包括向受试者施用本发明的药物配方的治疗有效量。
    公开号:
    WO2012074999A1
  • 作为产物:
    描述:
    2,4-Dichlor-6-propylamino-s-triazin乙胺盐酸盐 在 sodium hydroxide 作用下, 以 丙酮 为溶剂, 反应 0.67h, 以92%的产率得到氯代石蜡
    参考文献:
    名称:
    [EN] NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
    [FR] NOUVEAUX COMPOSÉS COMME STIMULANTS RESPIRATOIRES POUR LE TRAITEMENT DE TROUBLES OU DE MALADIES DE CONTRÔLE DE LA RESPIRATION
    摘要:
    本发明涵盖了用于治疗患有呼吸控制疾病或紊乱的受试者的组合物。本发明还包括一种治疗患有呼吸系统疾病或紊乱的受试者的方法,包括向受试者施用本发明的药物配方的治疗有效量。本发明还包括一种预防或稳定患有呼吸节律不稳定的受试者的方法,包括向受试者施用本发明的药物配方的治疗有效量。
    公开号:
    WO2012074999A1
点击查看最新优质反应信息

文献信息

  • Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
    申请人:Mannion James C.
    公开号:US20120295911A1
    公开(公告)日:2012-11-22
    The present invention includes compositions that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention.
    本发明包括用于治疗需要呼吸控制疾病或障碍的受体的组合物。本发明还包括一种治疗需要呼吸系统疾病或障碍的受体的方法,包括向受体施用本发明的药物制剂的治疗有效量。本发明还包括一种预防或稳定需要呼吸节律的受体的方法,包括向受体施用本发明的药物制剂的治疗有效量。
  • Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases
    申请人:Dax Scott L.
    公开号:US20120142647A1
    公开(公告)日:2012-06-07
    The present invention includes compositions that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention.
    本发明包括用于治疗呼吸控制疾病或障碍的组合物,适用于需要该治疗的受试者。本发明还包括一种治疗呼吸系统疾病或障碍的方法,包括向受试者投予本发明的药物制剂的治疗有效量。本发明还包括一种预防或稳定受试者呼吸节律不稳定的方法,包括向受试者投予本发明的药物制剂的治疗有效量。
  • NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
    申请人:GALLEON PHARMACEUTICALS, INC.
    公开号:US20140371224A1
    公开(公告)日:2014-12-18
    The present invention includes compounds, and compositions comprising the same, that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of the invention.
    本发明包括化合物及其组合物,适用于治疗需要治疗呼吸控制疾病或障碍的患者。本发明还包括一种治疗需要治疗呼吸系统疾病或障碍的患者的方法,包括向患者施用本发明中化合物的治疗有效量。本发明还包括一种预防或稳定需要稳定呼吸节律的患者的方法,包括向患者施用本发明中化合物的治疗有效量。
  • NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
    申请人:GALLEON PHARMACEUTICALS, INC.
    公开号:US20160256463A1
    公开(公告)日:2016-09-08
    The present invention includes a composition comprising a compound, such as a 2,4,6-triamino-1,3,5-triazine, 2,4,6-triaminopyrimidine, 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine or 2,4-diamino-7H-pyrrolo[2,3-d]pyrimidine, that is useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition of the invention. The present invention further includes a method of preventing destabilizing or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition of the invention.
    本发明涉及一种组合物,包括化合物,如2,4,6-三氨基-1,3,5-三嗪、2,4,6-三氨基嘧啶、2,4-二氨基-6,7-二氢-5H-吡咯[2,3-d]嘧啶或2,4-二氨基-7H-吡咯[2,3-d]嘧啶,其在治疗需要该类治疗的呼吸控制疾病或障碍的患者中有用。本发明还包括一种治疗需要该类治疗的呼吸系统疾病或障碍的患者的方法,包括向该患者施用本发明的药物组合物的治疗有效量。本发明还包括一种预防需要该类治疗的患者呼吸节律不稳定或稳定的方法,包括向该患者施用本发明的药物组合物的治疗有效量。
  • Herbicidal compositions
    申请人:ISAGRO S.p.A.
    公开号:EP2359692A1
    公开(公告)日:2011-08-24
    A description follows of compositions with a herbicidal activity containing the compound having formula (I): mixed with tribenuron and/or its methyl salt, possibly stabilized by the addition of at least one inorganic or organic base, and the relative use for the control of weeds in agricultural crops.
    下面介绍含有式(I)化合物的具有除草活性的组合物: 和/或其甲基盐(可能通过添加至少一种无机或有机碱而稳定)混合而成的具有除草活性的复合物,以及该复合物在控制农作物杂草方面的相关用途。
查看更多